RVLPQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RVLPQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
RVL Pharmaceuticals has the Momentum Rank of 0.
For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.
Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.
For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Thank you for viewing the detailed overview of RVL Pharmaceuticals's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Foundation Harsaul | 10 percent owner | EDIFICIO AFRA, AVENIDA SAMUEL LEWIS Y CALLE 54, PANAMA R1 |
Altchem Ltd | 10 percent owner | KARAISKAKI 6, CITY HOUSE, LIMASSOL G4 3032 |
Alisa Lask | director | C/O 380 LACKAWANNA PLACE, SOUTH ORANGE NJ 07079 |
David F Burgstahler | director, 10 percent owner | C/O WARNER CHILCOTT HOLDINGS CO., LTD., 100 ENTERPRISE DRIVE, ROCKAWAY NJ 07866 |
Athyrium Opportunities Associates Iv Co-invest Llc | 10 percent owner | 505 FIFTH AVENUE, FLOOR 18, NEW YORK NY 10017 |
Athyrium Opportunities Associates Iv Lp | 10 percent owner | 505 FIFTH AVENUE, FLOOR 18, NEW YORK NY 10017 |
Athyrium Opportunities Associates Iv Gp Llc | 10 percent owner | 505 FIFTH AVENUE, FLOOR 18, NEW YORK NY 10017 |
Athyrium Opportunities Iv Co-invest 2 Lp | 10 percent owner | 505 FIFTH AVENUE, FLOOR 18, NEW YORK NY 10017 |
Athyrium Opportunities Iv Acquisition 2 Lp | 10 percent owner | 505 FIFTH AVENUE, FLOOR 18, NEW YORK NY 10017 |
Athyrium Funds Gp Holdings Llc | 10 percent owner | 505 FIFTH AVENUE, FLOOR 18, NEW YORK NY 10017 |
Avista Healthcare Partners, L.p. | 10 percent owner | 65 E. 55TH STREET, 18TH FLOOR, NEW YORK NY 10022 |
Brian A Markison | director, officer: Chief Executive Officer | 501 FIFTH STREET, BRISTOL TN 37620 |
Sriram Venkataraman | director, 10 percent owner | C/O AVISTA CAPITAL PARTNERS, 65 EAST 55TH STREET, 18TH FLOOR, NEW YORK NY 10022 |
Jeffrey Ferrell | 10 percent owner | ATHYRIUM CAPITAL MANAGEMENT, LP, 505 FIFTH AVENUE, FL 18, NEW YORK NY 10017 |
James Schaub | officer: EVP and COO | 400 CROSSING BOULEVARD, C/O OSMOTICA PHARMACEUTICALS PLC, BRIDGEWATER NJ 08807 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 06-16-2022
By Value_Insider Value_Insider • 12-01-2022
By GlobeNewswire GlobeNewswire • 08-04-2022
By sperokesalga sperokesalga • 06-15-2023
By PRNewswire PRNewswire • 06-08-2022
By PurpleRose PurpleRose • 08-04-2022
By PRNewswire PRNewswire • 06-18-2022
By Stock market mentor Stock market mentor • 01-09-2023
By Marketwired • 07-05-2023
By PurpleRose PurpleRose • 08-04-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.